Biospectrix rapid blood test gets breakthrough designation

July 2, 2018 0 By CH Unnikrishnan

US FDA granted Breakthrough Device designation to Biospectrix, a new technology developed by 3i Diagnostics for detecting and identifying bacteria directly from whole blood in less than an hour.

Biospectrix does not require culturing and identifies a broad range of bacteria in less than 1 hour directly from the patient sample as opposed to the 2-6 days needed for culture. Such a system can help initiate treatment using the appropriate antibiotic rapidly, and potentially reduce bacteria-related mortality, complications, and treatment costs.